Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any - 20 |
| Updated: | 2/3/2018 |
| Start Date: | March 2012 |
| End Date: | December 2019 |
The purpose of the study is to provide comprehensive follow-up in patients with Long QT
Syndrome (LQTS) and gain additional information regarding genotype-phenotype correlation and
effective management and treatment options.
Syndrome (LQTS) and gain additional information regarding genotype-phenotype correlation and
effective management and treatment options.
Inclusion Criteria:
- Children and/or young adults diagnosed with heterogeneous repolarization disorder who
have genotype positive Long QT, or
- Newly diagnosed mutation positive patients with a confirmed test
Exclusion Criteria:
- Children who are phenotypically positive with no molecular testing
- Children that are phenotypically positive but genotype negative
We found this trial at
2
sites
Phoenix, Arizona 85006
Principal Investigator: Mitchell Cohen, MD
Phone: 602-253-6000
Click here to add this to my saved trials
Austin, Texas 78756
Principal Investigator: Arnold Fenrich, MD
Phone: 512-480-0143
Click here to add this to my saved trials